Imidazothiazole Derivatives Exhibited Potent Effects against Brain-Eating Amoebae

Area of Science:

• Parasitology
• Medicinal Chemistry
• Neuroscience

Background:

• Naegleria fowleri (N. fowleri) causes fatal primary amoebic meningoencephalitis (PAM).
• Climate change is increasing the risk of N. fowleri infections.
• There is an urgent need for new therapeutic drugs due to limited treatment options.

Purpose of the Study:

• To synthesize novel compounds and evaluate their anti-amoebic properties against N. fowleri.
• To identify compounds effective in reducing N. fowleri viability and host cell death.

Main Methods:

• Synthesis of target chemical compounds.
• In vitro testing of compounds against N. fowleri.
• Assessment of amoebicidal activity and host cell death reduction.
• Determination of minimum inhibitory concentration (MIC50) and cytotoxicity.

Main Results:

• Several compounds demonstrated significant amoebicidal effects, reducing N. fowleri viability.
• Compounds 1f, 1k, and 1v notably reduced amoeba-mediated host cell death.
• MIC50 values were determined for promising compounds, indicating potency.
• Most synthesized compounds exhibited limited cytotoxicity.

Conclusions:

• The synthesized compounds show significant potential as therapeutic agents against N. fowleri.
• Further development of these compounds could lead to effective treatments for PAM.
• The study addresses the critical need for new drugs against brain-eating amoeba infections.